Axxam, a leading contract research organisation (CRO) providing integrated early discovery services and solutions across the life sciences industries, is pleased to announce its adoption of CDD Vault, a highly-regarded informatics platform from Collaborative Drug Discovery (CDD). This decision will enhance Axxam’s ability to manage and analyse complex scientific data, supporting its clients’ drug discovery [...]

New, groundbreaking technology delivers Illumina's mostcomprehensive genome yet; early results from Broad Clinical Labs demonstrate a highly simplified workflow, ultra-long phasing, high-resolution insights into complex genomic variation,and enhanced long-range information   Illumina and customers will also showcase new details on complete proteomics solution and latest data on Fluent single-cell technology SAN DIEGO -- Illumina, Inc. [...]

Cure51 plans to analyze more than 1,000 tumor samples from exceptional cancer survivors PARIS and PLEASANTON, Calif. -- French TechBio startup Cure51 and 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today that Cure51 will deploy 10x Genomics' Visium HD as part of its pioneering work to understand the unique biology of exceptional cancer survivors, [...]

SAN DIEGO -- Inocras, a leader in whole genome sequencing (WGS) and bioinformatics, has introduced MRDVision, a minimal residual disease (MRD) detection solution showcasing a limit of detection (LOD) down to one-in-a-million. MRDVision combines Inocras’s WGS cancer profiling platform, CancerVision, and Ultima Genomics’ ppmSeq™ technology to deliver high-accuracy detection of circulating tumor DNA. This assay [...]

Rapid, Highly Sensitive Detection of Structural Variants Now Possible Using Standard Short-Read Sequencing Platforms SCOTTS VALLEY, Calif. -- Dovetail Genomics, a leading innovator in genomic solutions, today announces the commercial launch of its LinkPrep™ technology for genetic variant detection at American Society of Human Genetics (ASHG) conference. Data will be presented in a workshop session by investigators at Indiana University, one [...]

Set to become the fastest amplicon sequencing protocol on the market, Amp-Seq One offers reduced hands-on time and doubled throughput for customers. LGC Biosearch Technologies™, a pioneer in agricultural genomics, today has announced the development of a revolutionary one-step amplicon sequencing workflow called Amp-Seq One that promises to be as fast as end-point genotyping with [...]

Opening of Biosynth Biological Technology; a new Cutting-Edge Facility at Lifebay in Suzhou, China Staad – Biosynth, a leading developer and supplier of critical raw materials and services for diagnostics, vaccines, and pharmaceutical industries, is pleased to announce the opening of its Biosynth Biological Technology site at Lifebay, an innovative technology park in Suzhou, China. [...]

BURLINGTON, Mass. -- Azenta, Inc. (Nasdaq: AZTA) today announced the launch of a long-read Whole Genome Sequencing (WGS) test for clinical applications. Azenta becomes the first commercial provider to obtain regulatory approval to offer this test in the United States. Traditional short-read sequencing methods often struggle with identifying genetic variants in repetitive regions of the [...]

WILMINGTON, Del. -- Geneyx Inc. a pioneering global company for an AI Multi-Omics analysis system, and [Pittsburgh, PA] Ocean Genomics, a leader in AI-ready Multi-Omics data, are pleased to announce the release of SVDuo™, an innovative software now available on Geneyx Analysis for research and clinical application and integrated into Ocean's TxomeAI®. This advancement combines DNA and RNA [...]

Waltham, MASS – Thermo Fisher Scientific Receives authorization for sale for the EXENT® System* in Australia**, Enhancing the Assessment of Patients with Monoclonal Gammopathies  Image: EXENT-iQ®500 (Left), EXENT-iX® (Right), EXENT-iP®500 (Back)   Overview: Building on the clinical validation and IVDR Certification*** of the EXENT® System, Thermo Fisher Scientific has now received regulatory authorization for the clinical use of [...]